Together we will beat cancerDonate
In 1930, it was discovered that children with Down syndrome are at a greater risk of developing certain types of leukaemia, but much of our understanding of this link remains a mystery.
Since the 1970s, 30,000 deaths have been avoided thanks in part to the progress we’ve made in diagnosing and treating children’s and young people’s cancers.
The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland
Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.
Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.
Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.
An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.
Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto
A cancer immunotherapy will be offered on the NHS in England to some children and young adults with leukaemia, NHS England announced today.
A combination of two immunotherapy drugs outperformed a single drug treatment in patients with a type of advanced lung cancer.